Varamir
Desk
News
Calendar
Pricing
Saved
Search
tickers or companies
⌘K
Start free
· no card
Sign in
VOR compared with AMGN: revenue, margins and what each company keeps, and the suppliers and customers both name
VOR
Vor Biopharma Inc.
Change
Mkt cap
Revenue
Revenue
AMGN
Amgen Inc
Change
Mkt cap
Revenue
Revenue
vs
Compare
VOR
Vor Biopharma Inc.
vs
AMGN
Amgen Inc
Price
Mkt cap
Revenue
Revenue
Change
Change
Revenue flow
Supply chain
Price
Co-movers
Event sensitivity
Earnings history
Save comparison
Copy link
Supply-chain overlap
Desk
News
Calendar
Saved
Search
Supply-chain overlap
direct ties · both sides
Sources
›
direct ties · both sides
Only VOR
3
—
RemeGen
unlisted
supplier
—
The Trustees of Columbia University in the City of New York
unlisted
customer
—
U.S. Department of Health and Human Services, as represented by National Cancer Institute of the National Institutes of Health
unlisted
customer
Shared
0
No shared counterparties.
Only AMGN
12
PODD
Insulet
supplier
CYTK
Cytokinetics
supplier
ARWR
Arrowhead Pharmaceuticals
supplier
LGND
Ligand Pharmaceuticals
supplier
Role chip = supplier or customer
—
= no ticker (unlisted)
Source: SEC EDGAR
8 more · AMGN chain
›
VOR
Vor Biopharma Inc.
Change
19.86
▲
+6.44%
· post 19.99
Mkt cap
$1.2B
Revenue
—
Revenue
—
AMGN
Amgen Inc
Change
460.55
▲
+0.06%
· post 460.42
Closed
Nov 6 '26
Mkt cap
$249.0B
Revenue
$10.4B
Q3 FY26
Revenue
$36.8B
FY25
vs
Compare
Closed
Nov 6 '26
VOR
Vor Biopharma Inc.
vs
AMGN
Amgen Inc
19.86
▲
+6.44%
post 19.99
Price
460.55
▲
+0.06%
post 460.42
$1.2B
Mkt cap
$249.0B
—
Revenue
$10.4B
Q3 FY26
—
Revenue
$36.8B
FY25
Change
Change
VOR
19.86
▲
+6.44%
vs
AMGN
460.55
▲
+0.06%
Closed
Nov 6 '26